Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visanne vs Microgynon for Endometriotic Cyst Recurrence
NCT02385448Phase 4Unknown
- Sponsor
- The University of Hong Kong
- Start
- Feb 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dienogest in endometriosis, sponsored by The University of Hong Kong. Primary endpoint: Recurrence of ovarian endometrioma at 104 weeks. Status: unknown.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02385448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385448.